Since the evaluation of the cryoballoon in the Sustained Treatment Of Paroxysmal Atrial
Fibrillation trial, more than 350,000 patients with atrial fibrillation have been treated. Several …

Abstract Atrial fibrillation (AF) affects 1–2% of the population, and its prevalence is estimated
to double in the next 50 years as the population ages. AF results in impaired patients' life …

Catheter ablation is the most effective treatment option for patients suffering from
symptomatic atrial fibrillation. Electrical isolation of the pulmonary veins is the procedural …

Background Although a rare complication of catheter based ablation for atrial fibrillation
(AF), atrioesophageal fistula (AEF) is a serious and fatal event [[1],[2],[3],[4],[5]]. Most reports …

Atrial fibrillation remains the most common arrhythmia worldwide, with pulmonary vein
isolation (PVI) being an essential component in the treatment of this arrhythmia. In view of …

Pulmonary veins (PVs) are a major source of ectopic beats that initiate AF. PV isolation from
the left atrium is an effective therapy for the majority of paroxysmal AF. However …

Atrial fibrillation is the most common cardiac arrhythmia and the prevalence is increasing
every year. Patients who fail to maintain sinus rhythm with use of anti-arrhythmic drug …

The number of patients with atrial fibrillation currently referred for catheter ablation is
increasing. However, the number of trained operators and the capacity of many …

Background Rigid time-based dosing protocol (s) currently used in the clinic for cryoballoon
ablation of atrial fibrillation may be inadequate to guide the circumferential and transmural …

Background Pulmonary vein isolation (PVI) via catheter ablation is an approved therapy for
patients with drug-refractory and symptomatic atrial fibrillation (AF). Furthermore …